ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Biotechnology

Healthcare
$12.82 +0.73%

+$0.13 today

Market cap
$1.42B
Beta
0.00
52W Low $16.64High $23.21

Volume 0.65M

Average 1.06M

ADRX Other Current Liabilities

Short-term obligations not reported separately, such as accrued expenses.

No reported Other Current Liabilities figures are available to summarize.

Other Current Liabilities history

Currency unavailable · from the balance sheet

No Other Current Liabilities data reported for this period type.

Other Current Liabilities vs competitors

How ADRX compares with its peers on the latest reported figures

ADRX Competitors
Other Current Liabilities for ADRX and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
MGTXMeiraGTx Holdings plcMar 2026$119.74M USD+1274.9%+57.2%48.9%
STOKStoke Therapeutics, Inc.Mar 2026$18.39M USD+267.0%+33.9%4.1%
PRQRProQR Therapeutics N.V.Mar 2026€10.66M EUR+1.8%-13.4%10.7%
RNAAtrium Therapeutics, Inc.Mar 2026$6.98M USD——2.4%
WVEWave Life Sciences Ltd.Mar 2026$5.52M USD+23.8%+13.7%0.9%
ARCTArcturus Therapeutics Holdings Inc.Mar 2026$5.49M USD-13.6%+19.8%2.2%
PRMEPrime Medicine, Inc.Mar 2026$4.34M USD-37.1%+9.0%1.5%
BNTCBenitec Biopharma Inc.Mar 2026$541K USD+27.0%+2.1%0.3%
SLNSilence Therapeutics plcMar 2026$0 USD-100.0%-14.3%0.0%
ADRXADARx Pharmaceuticals, Inc.—— ———
Peer median (excluding ADRX) —+12.8%+11.4%2.2%

Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Intrinsic Alpha fair value

Locked

Current Price

$12.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.